Spun out of laboratories at Stanford University and MIT/Broad Institute and headquartered in Boston with a satellite office in San Diego, Stellaromics is the leader in 3D spatial biology.
The company's flagship offering is Pyxa®, the first commercial platform for true 3D spatial multi-omics.
Pyxa is built on STARmap™ (Spatially-resolved Transcript Amplicon Readout mapping), an in situ sequencing chemistry that reveals gene expression at subcellular resolution in intact, thick tissue up to 100 µm rather than inferring it from thin 2D slices. Pyxa detects hundreds of transcripts at subcellular resolution through a comprehensive workflow that includes sample preparation, volumetric imaging, and 3D data visualization in PyxaStudio™ — producing detailed maps of gene expression and cell typing that deepen our understanding of disease. Researchers around the globe are using Pyxa to study the tumor microenvironment, neural circuits and neurodegenerative diseases, developmental biology, and more.
To bring Pyxa's true 3D spatial multi-omics capabilities to your institution, please visit our website at stellaromics.com.